Introduction {#sec1}
============

Distal radius fractures (DRFs) which account for 44% of all types of hand and forearm fractures[@bib1] represent the most common type of fracture of the upper extremity and pose a serious public health concern.[@bib2] DRFs are common in old people with osteoporosis and often caused by low energy injury or a simple fall in this population. Economic costs of care of DRFs are more than USD 480 million in the United States annually.[@bib3] The burden of DFRs and the costs of cares are expected to grow, since the population aging.[@bib4] Unfortunately, the treatment for DRFs is controversial. Therefore, determining effective evidence-based treatment of DRFs is crucial.

Over the last 30 years, many different treatment methods have been recommended: cast immobilization, external fixation (EF), open reduction and internal fixation with a volar or dorsal plate. The best choice of treatment for DRFs remains a topic of controversy. The EF is a minimal invasive method which is simple to perform, and rigid stability may be achieved by EF for DRFs. EF with bridging or non-bridging fixator could be applied for DRFs. Studies show that direct skeletal EF with bridging fixators and EF with non-bridging fixators result in fewer malunions and also have satisfactory function results.[@bib5], [@bib6], [@bib7] Volar locking plates (VLP) have been introduced to stabilise displaced DRFs from the volar side for several years. These have two theoretical advantages: reduction in extensor tendon problems and secure fixation of osteoporotic bone because of the fixed angle conferred by the locking screws. Additionally, using the VLP have an excellent advantage of biomechanics in treatment for the DRFs, but none of the recommendations in clinical practice guidelines for DRFs published by the American Academy of Orthopaedic Surgeons (AAOS) was given a "strong" rating owing to limited strength of the evidence. Furthermore, there were some complications related to VLP, such as flexor tendon problem,[@bib8] longitudinal fractures of the near cortex,[@bib9] tenosynovitis and tendon ruptures resulting from penetration of distal screws through the dorsal cortex[@bib10] and so on. Therefore, whether VLP are superior to EF in clinical results in the treatment for DRFs remains uncertain.

Many recent randomized controlled trials[@bib11], [@bib12] and retrospective studies[@bib13], [@bib14] have suggested that there are few differences between them in terms of postoperative results such as grip strength, pain, and range of motion, radiographic measurements, except the subjective assessment score.

We aimed to perform a meta-analysis of randomized trials and retrospective trials comparing the clinical, functional and radiological outcomes for distal radius fractures using VLP with EF.

Materials and methods {#sec2}
=====================

The meta-analysis followed the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guidelines.[@bib15]

Search strategy {#sec2.1}
---------------

We searched PubMed, Embase, and the Cochrane library from their inception to Dec 28th, 2017. The main search strategy for PubMed and Embase database entered were illustrated in [Table 1](#tbl1){ref-type="table"}, and no language restrictions were used. We also searched the references of reviews and included studies to ensure that all relevant studies were checked for the meta-analysis.Table 1Search strategy for PubMed and EMBASE.Table 1PubMed:\#1 randomized controlled trial \[PT\]EMBASE:(distal AND (radius OR radial)) AND (external AND fix\*) AND (((internal OR plate OR plates OR plating) AND fix\*) AND volar) AND (randomized OR randomly).mp. \[mp = title, abstract, subject headings, heading word, drug trade name, original title, device manufacturer, drug manufacturer name\]\#2 controlled clinical trial \[PT\]\#3 comparative study \[PT\]\#4 randomized \[tiab\]\#5 randomly \[tiab\]\#6 trial \[tiab\]\#7\#1 OR\#2 OR\#3 OR\#4 OR\#5 OR\#6\#8 distal radial fractures \[tiab\]\#9 distal radius fractures \[tiab\]\#10 distal radial \[tiab\]\#11 distal radius \[tiab\]\#12 colles fractures \[tiab\]\#13 smith fractures \[tiab\]\#14 wrist injuries \[tiab\]\#15\#8 OR\#9 OR\#10 OR\#11 OR\#12 OR\#13 OR\#14\#16 plate \[tiab\]\#17 locking plate \[tiab\]\#18 volar locking plate \[tiab\]\#19 volar plate \[tiab\]\#20 plate osteosynthesis \[tiab\]\#21 external fixation \[tiab\]\#22 external fixators \[tiab\]\#23\#16 OR\#17 OR\#18 OR\#19 OR\#20 OR\#21 OR\#22\#24\#7 AND\#15 AND\#23[^1]

Inclusion criteria {#sec2.2}
------------------

Studies were included in the meta-analysis if they met the following criteria: they were randomized controlled trials (RCTs) or retrospective cohort studies (CSs); they compared VLP and EF for patients with closed DRFs; they reported data on disability arm, shoulder and hand scores (DASH scores), Gartland-Werley scores (G-W scores), visual analogue scale scores (VAS scores), range of motion, radiological measurement, grip strength, and complications, and data were completely or partly available.

Exclusion criteria {#sec2.3}
------------------

Studies were excluded if they were experimental trials; data were incomplete or unavailable; they were non-original articles such as reviews, or letters and comments; or duplicated publications were excluded apart from the one with the most complete data.

Evaluated outcomes {#sec2.4}
------------------

Functional scores (DASH scores, G-W scores, VAS scores), wrist range of motion (flexion, extension, pronation, supination, ulnar deviation and radial deviation), radiological measurement (volar tilt, radial inclination, ulnar variance and radial length), grip strength and reported complications were evaluated.

Study selection {#sec2.5}
---------------

Duplicates were initially excluded. Two reviewers reviewed all studies independently by screening the titles and abstracts. The irrelevant articles were identified and eliminated. Subsequently, the remaining studies were assessed through full-text reading by two reviewers independently. Disagreements were settled by discussion. If the consensus could not be reached, the final decision was adjudicated by a third reviewer.

Data extraction {#sec2.6}
---------------

Two reviewers extracted the following data from the included studies independently, using the standardized data extraction method. They checked data each other for accuracy. The data extracted from the studies included title, published year, authors, country, study design, number of study center, sample size, age of subjects, sex distribution, the type of fracture, the type of interventions, duration of follow-up, and outcomes. We tried to obtain unpublished original raw data from the authors of each study by email. For all continuous outcomes, we extracted mean and standard deviations. When these values were not reported, *P* value or confidence intervals was used to calculate these values if possible. Differences and disagreements were settled by discussion.

Methodological quality assessment {#sec3}
=================================

Two reviewers independently assessed the methodological quality and the risk of bias of the included RCTs with a 12-item scale[@bib16] recommended by Cochrane Back Review Group. The following aspects were assessed: randomization, allocation concealment, similar baseline, patient blinded, care provider blinded, the outcome assessor blinded, selective reporting, avoided cofactors, patients\' compliance, drop-out rate, similar timing, and ITT analysis. The quality of retrospective cohort studies was assessed using Newcastle--Ottawa quality assessment scale for non-randomized case controlled studies and cohort studies (<http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp>).[@bib17] Three aspects were assessed: selection, comparability and exposure. Testing for publication bias was performed using funnel plots, Begg\'s test and Egger\'s test. The Begg\'s test and Egger\'s test were performed by software Stata 14.0 (Stata Corp, College Station, Tex). We also used the criteria of the Grading of Recommendations Assessment, Development and Evaluation (GRADE) to evaluate the quality of evidence.[@bib18]

Data synthesis and analysis {#sec3.1}
---------------------------

We prespecified separate analysis of RCTs and CSs given the inherent differences between these types of study designs.[@bib19] Mean differences (MD) with a 95% confidence interval (CI) were calculated to assess the effect size for continuous outcome data. Risk ratio (RR) with a 95%CI were used as effect size for dichotomous data. Inverse variance method and Mantel-Haenszel analysis method were used for continuous variables and dichotomous variables, respectively.[@bib20] The heterogeneity among the trials was assessed for significance with Q and quantified with *I*^2^. Statistically significant was set at the *P* value \< 0.10. The heterogeneity of the trials was divided into four levels: homogeneous (an *I*^2^ less than 25%), low heterogeneity (an *I*^2^ between 25% and 50%), moderate heterogeneity (an *I*^2^ between 50% and 75%), and high heterogeneity (an *I*^2^ above 75%). If the studies were homogeneous or the statistical heterogeneity was low, we used the fixed effect model. While, random effects model was applied when the statistical heterogeneity was moderate or high. Statistical analysis was undertaken with the software program RevMan 5.1 (The Nordic Cochrane Center, The Cochrane Collaboration, Copenhagen, Denmark).

Results {#sec4}
=======

Literature search and study characteristics {#sec4.1}
-------------------------------------------

[Fig. 1](#fig1){ref-type="fig"} illustrated the selection flow of studies in our meta-analysis. We retrieved 421 potential citations. After the title and abstract scanning, 26 full-text articles left to be assessed for eligibility. Ten RCTs[@bib11], [@bib12], [@bib21], [@bib22], [@bib23], [@bib24], [@bib25], [@bib26], [@bib27], [@bib28] and eleven CSs[@bib13], [@bib14], [@bib29], [@bib30], [@bib31], [@bib32], [@bib33], [@bib34], [@bib35], [@bib36], [@bib37] satisfied the inclusion criteria. A total of 1590 subjects with closed DRF (RCT: 908; CS: 682) were reported including 781 (RCT: 432; CS: 349) with VLP and 809 (RCT: 476; CS: 333) with EF. Five trials were excluded for different reasons. The data of one RCT[@bib38] were not enough. Included patients in one trial[@bib39] were same to the other included trial.[@bib28] One trial[@bib40] used inappropriate intervention (dorsal plate). One trial[@bib41] did not report the type of the plate (volar or dorsal?). The last one trial[@bib42] included open distal radius fractures.Fig. 1The flow diagram shows the selection process used in the study.Fig. 1

[Table 2](#tbl2){ref-type="table"}, [Table 3](#tbl3){ref-type="table"} summarized the characteristics of included RCTs and CSs, respectively. All included trials had comparable baseline in demographic characteristics, except four trials.[@bib26], [@bib29], [@bib30], [@bib36] The follow-up periods of all CSs were longer than that of RCTs. Therefore, the data at the end of the follow-up of each included trial were used in synthesis and analysis.Table 2Characteristics of included RCTs.Table 2Study typeIncluded studiesCountryStudy centerSample size (VLP/EF)Female (VLP/EF)Mean age (VLP/EF)(years)Fracture typeIntervention (VLP/EF)Follow-up time (months)Randomized controlled trialsJeudy 2012FranceTwo36/3926/3164.7/64.6AO C2-3VLP/EF6Wilcke 2011SwedenOne33/3025/2355/56AO A/C1VLP/bridging EF12Wei 2009USAOne12/229/1961/55AO A/CVLP/bridging EF12Egol 2008USAOne38/3925/2252.2/49.9AO A/B/CVLP/bridging EF12Gradl 2013USAOne52/5089^§^63^§^AO A3/C1-3VLP/non-bridging EF12Williksen 2013NorwayOne52/5989^§^54^§^AO A2-3/C1-3VLP/bridging EF12Shukla 2014IndiaOne42/6828/3339.12^§^Cooney\'s type IVVLP/bridging EF12Roh 2015KoreaOne36/387/854.4/55.3AO C2-3VLP/EF12Sha 2015ChinaOne61/6152/5064.7/64.4AO C1-3VLP/bridging EF12--28Navarro 2016SwedenOne70/7063/6663/63AO A2-3/C1-3VLP/bridging EF12[^2]Table 3Characteristics of included CSs.Table 3Study typeIncluded studiesCountryStudy centerSample size (VLP/EF)Female (VLP/EF)Mean age (VLP/EF)(years)Fracture typeIntervention (VLP/EF)Follow-up time (months)Retrospective cohort studiesRichard 2011USAOne56/5928/3150/50AO C2-3VLP/EF12Jorge-Mora 2012SpainOne40/4024/2152/45AO A/B/C1-3VLP/EF15Schmelzer-Schmied 2009GermanyOne15/15NR60^§^AO C1-2VLP/bridging EF\>12Rizzo 2008USAOne41/1425/848/45Melone type IIVLP/EF25--36Wright 2005USAOne21/1110/850.1/50NRVP/bridging EF12--84Westphal 2005GermanyOne54/7728/4659.5/60.6AO A3/C2VP/EF12--40Kumbaraci 2014TurkeyOne34/3516/1848/52.6AO C1-3VLP/bridging EF12--72Gereli 2010TurkeyOne16/145/349/35AO C1-3VLP/bridging EF16--96Sato 2010JapanOne13/139/1169.7/65.8AO A/CVLP/bridging EF12--39Zhao 2011ChinaOne30/3026/2659.57/60/97AO A3/B2-3/C1-3VP/bridging EF12--18Yang 2013ChinaOne29/2513/1245.72/44.84AO C1-3VLP/bridging EF12--24[^3]

Study quality assessment {#sec4.2}
------------------------

The methodological quality of one RCT[@bib25] was low, while the quality of left RCTs was moderate. All included RCTs did not adapt blind methods (patient, care provider and outcome assessor). Two trials[@bib11], [@bib27] did not describe the randomizing method, and four trials[@bib12], [@bib22], [@bib24], [@bib25] did not report the allocation concealed method ([Table 4](#tbl4){ref-type="table"}).Table 4Methodological quality assessment of included randomized controlled trials.Table 4Included studiesRandomized adequately[a](#tbl4fna){ref-type="table-fn"}Allocation concealedSimilar baselinePatient blindedCare provider blindedOutcome assessor blindedAvoided selective reportingSimilar or avoided cofactorsPatients\' compliance[b](#tbl4fnb){ref-type="table-fn"}Acceptable drop-out rate[c](#tbl4fnc){ref-type="table-fn"}Similar timingITT[d](#tbl4fnd){ref-type="table-fn"} analysisQuality [\#](#tbl4fn1){ref-type="table-fn"}Jeudy 2012YesYesYesNoNoNoYesNoNoYesYesNoModerateWilcke 2011UnclearYesYesNoNoNoYesYesNoYesYesUnclearModerateWei 2009YesYesNoNoNoYesYesNoNoNoYesYesModerateEgol 2008YesYesYesNoNoNoYesNoNoYesYesNoModerateGradl 2013YesUnlearYesNoNoNoYesNoNoYesYesUnclearModerateWilliksen 2013YesYesUnclearNoNoNoYesYesNoYesYesUnclearModerateShukla 2014YesUnclearYesNoNoNoNoNoNoYesYesUnclearLowRoh 2015YesUnclearYesNoNoNoYesYesNoYesYesUnclearModerateSha 2015YesUnclearYesNoNoNoNoYesNoYesYesUnclearModerateNavarro 2016UnclearYesYesNoNoNoNoYesNoYesYesUnclearModerate[^4][^5][^6][^7][^8]

Seven CSs achieved 7 scores, two achieved 6 score, one achieved 5 score and one achieved 4 score. The quality of all CSs was moderate to high, except Gereli\'s trial[@bib29] ([Table 5](#tbl5){ref-type="table"}).Table 5Quality assessment according to the Newcastle--Ottawa scale.Table 5StudySelectionComparabilityExposureTotal scoreRichard 20113227Jorge-Mora 20124026Schmelzer-Schmied 20093227Rizzo 20083227Wright 20053025Westhal 20053227Kumbaraci 20143227Gereli 20102024Sato 20103227Zhao 20113227Yang 20132226

DASH scores, G-W scores and VAS scores {#sec4.3}
--------------------------------------

Four RCTs[@bib21], [@bib26], [@bib27], [@bib28] and five CSs[@bib29], [@bib31], [@bib33], [@bib34], [@bib35] reported the DASH scores. Both included RCTs and CSs demonstrated that the DASH scores of VLP group was significantly better than that of EF group (RCT: MD = −6.12, 95%CI = −12.07--0.17, *P* = 0.04, *I*^2^ = 66%; CS: MD = −6.43, 95%CI = −12.53--0.34, *P* = 0.04, *I*^2^ = 79%) ([Fig. 2](#fig2){ref-type="fig"}). Only three CSs[@bib13], [@bib14], [@bib29] reported G-W scores, and two CSs[@bib31], [@bib34] reported VAS scores. The results of a heterogeneity test indicated that there was no significant heterogeneity among the included CSs *I*^2^*PI*^2^*P*. There were no significant differences in G-W scores*P* and VAS scores *P* between the two groups ([Table 6](#tbl6){ref-type="table"}).Fig. 2The forest plot shows the mean difference in DASH scores between VLP and EF. a: DASH scores in RCTs; b: DASH scores in CSs.Fig. 2Table 6Illustration of outcomes of the RCTs and CSs.Table 6CategoryStudy typeNo. RCTs No. CSsVLPEF*I*^2^Effect modelRRMD95% CI*P*-valueG-W scoreCS379740%Fixed--−0.39\[−0.88, 0.10\]0.12VAS scoreCS271740%Fixed--−0.81\[−1.67, 004\]0.06FlexionRCT413614051%Random--−0.71\[−5.19, 3.78\]0.76CS3656469%Random--7.90\[3.02, 12.78\]0.002\*ExtensionRCT413614064%Random--1.78\[−4.36, 7.93\]0.57CS3656441%Fixed--2.23\[−0.47, 4.92\]0.11PronationRCT413614069%Random--3.60\[−0.41, 7.60\]0.08CS3656428%Fixed--5.69\[3.53, 7.85\]\<0.00001\*SupinationRCT413614072%Random--−0.17\[−4.51, 4.17\]0.94CS3656474%Random--6.35\[1.12, 11.57\]0.02\*Ulnar deviationRCT413614038%Fixed--0.06\[−3.02, 3.14\]0.97CS3656463%Random--0.99\[−0.86, 2.83\]0.29Radial deviationRCT41361400%Fixed--−2.76\[−6.36, 0.84\]0.13CS3656442%Fixed--1.49\[0.18, 2.80\]0.03\*Volar tiltRCT519821368%Random--1.60\[−0.12, 3.31\]0.07CS928730894%Random--2.99\[0.62, 5.36\]0.01\*Radial inclinationRCT414815981%Random--−0.50\[−2.19, 1.19\]0.56CS721623435%Fixed--0.39\[0.07, 0.71\]0.02\*Ulnar varianceRCT41371520%Fixed--−0.81\[−1.25, −0.37\]0.0003\*CS621323879%Random--−0.22\[−1.05, 0.61\]0.61Radial lengthRCT416217556%Random--−0.26\[−0.62, 1.13\]0.56CS516318148%Fixed--−0.01\[−0.30, 0.27\]0.93InfectionRCT73383530%Fixed0.25--\[0.07, 0.42\]0.005\*CS82772650%Fixed0.17--\[0.06, 0.40\]0.0001\*CRPSRCT73263430%Fixed0.78--\[0.44, 1.40\]0.41CS51651770%Fixed0.31--\[0.12, 0.79\]0.01\*CTSRCT73393420%Fixed1.67--\[0.75, 3.72\]0.21CS31031270%Fixed4.12--\[0.69, 24.53\]0.12RSDCS271740%Fixed0.26--\[0.03, 2.19\]0.21[^9]

Wrist range of motion (ROM) {#sec4.4}
---------------------------

Pooling of wrist ROM data was possible across four[@bib21], [@bib22], [@bib26], [@bib27] of the ten RCTs, and three[@bib13], [@bib29], [@bib34] of the CSs. No heterogeneity was detected for radial deviation in RCTs*I*^2^*P*. Low to moderate heterogeneities were found in any other ROM variables *I*^2^. The pooled treatment effect showed significant differences favoring VLP for flexion, pronation, supination and radial deviation in CSs *P*. While no significant differences were detected for these ROM variables in RCTs*P*. No significant differences were detected in extension and ulnar deviation in RCTs*P* and CSs*P* ([Table 6](#tbl6){ref-type="table"}).

Radiological measurement {#sec4.5}
------------------------

Five RCTs[@bib12], [@bib21], [@bib24], [@bib26], [@bib28] and nine CSs[@bib13], [@bib14], [@bib29], [@bib30], [@bib31], [@bib33], [@bib34], [@bib35], [@bib37] reported volar tilt, four RCTs[@bib12], [@bib21], [@bib24], [@bib26] and seven CSs[@bib13], [@bib14], [@bib29], [@bib30], [@bib33], [@bib35], [@bib37] reported radial inclination, four RCTs[@bib21], [@bib24], [@bib26], [@bib28] and six CSs[@bib13], [@bib29], [@bib30], [@bib31], [@bib33], [@bib35] reported ulnar variance and four RCTs[@bib12], [@bib21], [@bib26], [@bib28] and five CSs[@bib13], [@bib14], [@bib29], [@bib35], [@bib37] reported radial length. [Table 6](#tbl6){ref-type="table"} summarized the radiological measurement results. No heterogeneity was detected for ulnar variance in RCTs*I*^2^*P*. Low to high heterogeneity was detected in any other radiological measurement variables*I*^2^. According to the analysis of data extracted from CSs, there was significantly greater loss of volar tilt*P* and radial inclination*P* in patients receiving EF, compared with those receiving VLP. But no significant differences were detected according to the analysis of data extracted from RCTs*PP*. The analysis of data extracted from RCTs indicated that VLP lead to significantly better restoration of ulnar variance*P*, but no significant difference was detected for ulnar variance in CSs*P*. However, no statistical difference was found for radial length in either RCTs*P* or CSs*P* ([Table 6](#tbl6){ref-type="table"}).

Grip strength {#sec4.6}
-------------

Six RCTs[@bib21], [@bib22], [@bib24], [@bib26], [@bib27], [@bib28] reported the grip strength of participants. Fixed effects model was implemented since low heterogeneity was found in this comparison (*I*^2^ = 25%, *P* = 0.25). No significant difference for grip strength in the pooled treatment effect (MD = 2.80, 95%CI = −0.97--6.57, *P* = 0.15). Only one CS[@bib31] reported the grip strength. There was significantly improved grip strength in the VLP group compared to the EF group (*P* = 0.007).

Complications {#sec4.7}
-------------

Ten RCTs and eight CSs reported the complication rate. The meta-analysis of total complication rate showed no significant difference in RCTs (RR = 0.84, 95%CI = 0.68--1.04, *P* = 0.11, *I*^2^ = 0%), but significantly lower complication rate for VLP group in CSs (RR = 0.32, 95%CI = 0.22--0.45, *P* \< 0.00001, *I*^2^ = 19%) ([Fig. 3](#fig3){ref-type="fig"}). Both RCTs and CSs showed significant differences in infection rate favoring VLP*P*. However, both RCTs and CSs showed no significant differences for carpal tunnel syndrome (CTS) rate*P*. A significant difference favoring VLP in CSs*P* and no significant difference in RCTs was detected for complex regional pain syndrome (CRPS). Only two of the included CSs reported the Reflex Sympathetic Dystrophy (RSD), and no significant difference was detected between the two groups ([Table 6](#tbl6){ref-type="table"}).Fig. 3The forest plot shows risk ratio in total complication rate between VLP and EF. a: total complication rate in RCTs; b: total complication rate in CSs.Fig. 3

Strength of evidence {#sec4.8}
--------------------

In the GRADE system of rating quality evidence, the quality evidence of ulnar variance and carpal tunnel syndrome was moderate in RCT group. The quality evidence of the total complication rate was very low. The quality evidence of the rest of outcomes in RCT group was low. All of the outcomes in the CS group achieved the very low quality evidence. (Supplementary materials).

Publication bias {#sec4.9}
----------------

Funnel plots generated in this meta-analysis that indicated the overall postoperative complications in RCTs and volar tilt in CSs are shown in [Fig. 4](#fig4){ref-type="fig"}. The shapes of the funnel plot in RCTs reveal slight asymmetry, which indicated some evidence of publication bias. However, the Begg\'s test and Egger\'s test showed that no statistical publication bias was detected (Begg\'s test *P* = 1.000; Egger\'s test *P* = 0.789). In CSs, we did not identify any significant graphic and statistical publication bias by the funnel plot, Begg\'s test (*P* = 0.754) and Egger\'s test (*P* = 0.776).Fig. 4a: The funnel plot of total complication rate shows the publication bias in RCTs. b: The funnel plot of total complication rate shows the publication bias in CSs.Fig. 4

Discussions {#sec5}
===========

The present meta-analysis included not only the RCTs, but also CSs. We aim to find more evidence to compare the VLP to EF for the treatment of DRFs. No contradictory results were found between the RCTs and CSs. Our meta-analysis indicated that the VLP lead to significantly lower DASH scores and infection rate than EF at the end of follow-up period both in RCTs and CSs. According to the analysis of the data extracted from RCTs, VLP associated with significantly better restoration in ulnar variance comparing with EF. Basing on the analysis of the data extracted from CSs, VLP lead to significantly better flexion, pronation, supination and radial deviation range of motion, and better restoration in volar tilt and radial inclination. Furthermore, there was a significantly greater rate of total complication in the EF group, as well the CRPS. The observed differences between the findings with RCTs and CSs demonstrated that reliance on neither should be absolute, but the collective data appeared consistent confirming the presence of significant efficacy of VLP in many assessment outcomes.

RCT and CS have their individual strengths and limitations that affect the clinical context and interpretation of their results. RCT data represents the purest comparison between the two treatment strategies and can minimize treatment selection bias, since it can minimize the influence of both measured and unmeasured confounders. While, CSs may be more generalizable and less subject to enrollment bias. Hannan[@bib19] indicated that RCTs and observation studies could be used synergistically to obtain more and better information about the relative merits of alternative interventions/treatments. Therefore, both types of data are useful in assessing the relative efficacy of VLP compared with EF.

Our meta-analysis included ten RCTs, nine of which achieved moderate methodological assessment. Only one RCT achieved low methodological assessment. The number of the RCTs was more than that of the published meta-analysis,[@bib43] offering newer and more robust evidence for the treatment of DRFs with VLP or EF. To compare with the results of meta-analysis of RCTs, CSs comparing VLP and EF for patients with DRFs were included. But we did not combine the included RCTs and CSs, because Cochrane group recommended that randomized trials and non-randomized trial should not be combined in a meta-analysis.[@bib44] The quality of CSs included in the meta-analysis was moderate to high, and only one was low quality. However, the publication bias of RCTs was detected. This maybe affect the robustness of evidence. A small group of positive industry-funded studies[@bib22], [@bib26] can suggest publication bias. Studies[@bib11], [@bib12], [@bib25] that did not avoid selective reporting of outcomes also can suggest publication bias.

It is known that anatomical restoration, early mobilization and minimal soft tissue trauma are the goal of open reduction and internal fixation of a DRF.[@bib45] DASH scores as the primary outcome revealed that, compared with EF, VLP led to superior performance in subjective outcome. One RCT[@bib38] also reported the similar results at six months after surgery. But another RCT[@bib39] reported that there was no significant difference for DASH scores at five years after surgery. One most possible explanation for this different outcomes could be that VLP osteosynthesis could restore the bony anatomy as a stable internal fixation, which could allow patients to get a more active early physiotherapy. But the DASH scores in EF group was improving with time and the difference between EF and VLP in DASH scores diminished after several years.

In CSs, Flexion, radial deviation, supination and pronation in VLP group were significantly better than those in the EF group. Since patients with VLP fixed typically are permitted earlier active wrist mobilization,[@bib46] it would be reasonable to expect this to contribute to some the advantage in ROM. Abnormalities in the anatomy of the wrist joint have been shown to lead to decreased range of motion.[@bib47] Dario\'s study[@bib48] shows that ulnar variance and volar tilt are the most important radiographic parameters to be restored to obtain good functional outcome in DRFs. Our meta-analysis showed that volar tilt, radial inclination and ulnar variance were significantly better in patients treated with VLP compared with EF. This was another explanation for differences in ROM. Chen[@bib49] and Orbay[@bib50] showed that compared with other methods of fixation, volar plating for DRFs allows for better anatomic reduction. This was similar to our meta-analysis. In RCTs, ulnar variance in VLP group was significantly better than that in the EF group. No heterogeneity was detected for ulnar variance. Hence, this result is credible. This is same for Zhang\'s study.[@bib43] One explanation is that VLP can offer better ability in controlling a variety of fractures and the fixation of VLP is firm. Biomechanical study[@bib51] has demonstrated that VLP can offer adequate strength to withdraw early postoperative motion. In RCTs, no statistical difference was detected in grip strength. However, one RCT[@bib39] followed five years and Richard\'s study[@bib31] show better grip strength in VLP group.

Other meta-analysis[@bib52] has reported that infections was more frequent in patients treated with EF, which is same to our meta-analysis. The difference of total complication rate and CRPS was significant in CSs, but not in RCTs. One conceivable explanation is that the period of follow-up in CSs is longer than those in RCTs. More complications could be investigated in VLP group, since few patients removed the plate. Study[@bib53] has reported that the incidence of 25% of RSD at 9 weeks after fracture and 17% 6 months after fracture. And the RSD was usually occurred in patients treated by EF.[@bib54] Only two CSs reported the RSD, and all of the patients suffered RSD were in EF group. However, no significant difference was detected. Additional studies were needed to evaluate this outcome.

According to the criteria of GRADE, the quality evidence of the outcomes was low to very low. The reasons as follows: 1. Two of the included studies didn\'t describe the randomization method; 2. Four studies didn\'t carry out allocation concealment; 3. One study had different baseline; 4. Nine studies didn\'t use ITT analysis or unclear. 5. The study design of CS and no factors that could upgrade the quality of evidence.

The results of this study should be interpreted with caution because of the following limitations. First, most of the statistically significant differences of the results were only in CSs, except DASH scores, infection rate and ulnar variance. Second, relatively small sample sizes of the included studies led to the limitation of our study and made the evidence weaker. Third, publication bias was detected in RCTs based on funnel plot, although the Begg\'s test and Egger\'s test did not detect statistical bias. The last, limited by the number of included studies in each outcome, we could not perform subgroup analysis and meta-regression to explore the source of heterogeneity.

Conclusions {#sec6}
===========

In conclusion, VLP could provide better results such as DASH scores, ulnar variance and infection rate. The use of VLP appears to be associated with better results of ROM (flexion, pronation, supination and radial deviation), radiographic parameters (volar tilt and radial inclination) and lower total complication rate and CRPS rate in CSs. Large, rigorous RCTs are needed to improve the evidence.
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[^1]: PT: Publication type; tiab: Title/Abstract.

[^2]: VLP: volar locking plate; EF: external fixation; NR: not reported; §: respective data are not available in the study.

[^3]: CSs: retrospective cohort studies; VLP: volar locking plate; EF: external fixation; NR: not reported; §: respective data are not available in the study.

[^4]: The frequencies of "Yes" ≥7 means "High"; \>4 and \<7 mean "Moderate"; ≤4 means "Low".

[^5]: Only if the method of sequence generated were explicitly described could get a "Yes"; sequence generated by "dates of admission" or "patients number" receive a "No".

[^6]: Intermittent treatment or therapeutic duration less than 6 months means "Yes", otherwise "No".

[^7]: Drop-out rate ≥30% means "No"; \<30% means "Yes".

[^8]: ITT: intention to treat, only if all randomized patients are analyzed in the group they were allocated to could receive a "Yes".

[^9]: RR: relative risk; MD: mean difference; CRPS: complex regional pain syndrome; CTS: carpal tunnel syndrome; RSD: Reflex Sympathetic Dystrophy. \* for significant values.
